Results 1 to 10 of about 751 (139)

Association of Serum Pepsinogens With Esophageal Squamous Cell Carcinoma Risk: A Systematic Review and Meta-Analysis [PDF]

open access: yesFrontiers in Oncology, 2022
BackgroundSerum pepsinogens are serological biomarkers of gastric atrophy, and the latter is a risk factor for esophageal squamous cell carcinoma (ESCC). However, the association of serum pepsinogens with ESCC risk remains unclear. This systematic review
Wenjing Zhao
exaly   +4 more sources

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
BackgroundAssociation of gastric atrophy or cancer with levels of serum pepsinogens, gastrin-17 and anti-Helicobacter pylori IgG antibody have been extensively studied. However, the association of serum pepsinogen and gastrin-17 with H.
Jun-peng Zhou   +15 more
doaj   +2 more sources

Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study [PDF]

open access: yesDiagnostics, 2022
Introduction––Serum pepsinogen tests for gastric cancer screening have been debated for decades. We assessed the performance of two pepsinogen assays with or without gastrin-17 for the detection of different precancerous lesions alone or as a composite ...
Claudia Robles   +15 more
doaj   +2 more sources

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. [PDF]

open access: yesPLoS ONE, 2020
Serum pepsinogens have been widely acknowledged as gastric mucosal biomarkers; however, a multicountry report on the benefits of pepsinogens as biomarkers has not yet been published.
Muhammad Miftahussurur   +13 more
doaj   +2 more sources

Serum Pepsinogens Combined with New Biomarkers Testing Using Chemiluminescent Enzyme Immunoassay for Non-Invasive Diagnosis of Atrophic Gastritis: A Prospective, Multicenter Study [PDF]

open access: yesDiagnostics, 2022
Background: Analysis of serum biomarkers for the assessment of atrophic gastritis (AG), a gastric precancerous lesion, is of growing interest for identification of patients at increased risk of gastric cancer.
Nicolas Chapelle   +14 more
doaj   +2 more sources

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study [PDF]

open access: yesHuman Genomics, 2019
Background Persistent infections that induce prolonged inflammation might negatively affect the leukocyte telomere length (LTL); however, the role in LTL of Helicobacter pylori (H.
Khitam Muhsen   +5 more
doaj   +2 more sources

Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. [PDF]

open access: yesPLoS ONE, 2015
BackgroundHuman pepsinogens are considered promising serological biomarkers for the screening of atrophic gastritis (AG) and gastric cancer (GC). However, there has been controversy in the literature with respect to the validity of serum pepsinogen (SPG)
Ya-kai Huang   +6 more
doaj   +2 more sources

The Role of Serum Pepsinogen Tests for Detecting Gastric Cancer Between Sexes and Among Age Groups [PDF]

open access: yesGut and Liver
Gastric cancer (GC) remains a significant concern worldwide, with a very high incidence in Japan, South Korea, and China. Early diagnosis of GC is important for reducing its mortality; to achieve this, screening of individuals at a high risk for ...
Seon Hee Lim, Yonghoon Choi, Nayoung Kim
doaj   +2 more sources

Serum pepsinogens and risk of esophageal squamous dysplasia. [PDF]

open access: yesInt J Cancer, 2009
AbstractPepsinogens are a class of endopeptidases that are secreted by the gastric epithelium and released into the circulation. Low serum pepsinogen I (PGI) and low serum pepsinogen I/pepsinogen II ratio (PGI/II ratio) are markers of gastric fundic atrophy, and have recently been shown to be associated with increased risk of esophageal squamous cell ...
Kamangar F   +10 more
europepmc   +4 more sources

Monitoring the follow-up of autoimmune chronic atrophic gastritis using parietal cell antibodies and markers of gastric function [PDF]

open access: yesJournal of Translational Autoimmunity
Increased interest in the pathogenesis and the evolution of autoimmune chronic atrophic gastritis (A-CAG) has led to the search for serological markers that can be used to detect changes in the gastric mucosa at an early stage and to monitor the course ...
Maria Piera Panozzo   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy